One gene, prepro-orexin, yields two peptides (orexin-A and -B) from a compact population of a few thousand neurons — among the smallest transmitter populations with the largest projection territory. These cells fire during wakefulness, go quiet in sleep, and are lost in human narcolepsy: the direct evidence that orexin is the brain's arousal stabilizer.
Receptor Actions
OX1 and OX2 receptors: GPCR excitation of the ascending arousal network — histamine, norepinephrine, serotonin nuclei.
Appetite effects gave the peptide its name (orexis, appetite) before its sleep role eclipsed it.
Tonic firing pattern: orexin neurons set gain on the whole wake system, not moment-to-moment switching.
Physiological Role
Stabilizes wakefulness: without orexin, sleep-wake boundaries blur — sleep attacks and cataplexy.
Metabolic integration: fires with low glucose and high ghrelin, quiets with leptin — feeding and arousal joined.
Reward-circuit innervation links arousal to motivation.
Interactions
Commands the histamine tuberomammillary nucleus — wakefulness's executive relay.
Mutual inhibition with melatonin's sleep pressure system.
Counter-regulated by adenosine sleep pressure — see adenosine.
Clinical Relevance
Narcolepsy type 1: autoimmune orexin-neuron loss — the disease that identified the system.
Dual orexin receptor antagonists (suvorexant, daridorexant): new insomnia drugs that disarm wakefulness.
Orexin agonism is the sought-after inverse — wakefulness therapy without stimulant physics.
Orexin's discovery traced narcolepsy to a peptide — psychiatry's sleep disorder rewritten as neurochemistry.
Orexin neurons integrate metabolic, circadian, and limbic input — the convergence zone for context-appropriate arousal.
CSF orexin measurement is narcolepsy's definitive diagnostic — a peptide assay replacing symptom description.
Orexin neurons also project to the pituitary axis and metabolic circuits — arousal wired into endocrinology.